CN1896090A - Δ9(11)甾体类化合物的制备方法 - Google Patents
Δ9(11)甾体类化合物的制备方法 Download PDFInfo
- Publication number
- CN1896090A CN1896090A CN 200510014479 CN200510014479A CN1896090A CN 1896090 A CN1896090 A CN 1896090A CN 200510014479 CN200510014479 CN 200510014479 CN 200510014479 A CN200510014479 A CN 200510014479A CN 1896090 A CN1896090 A CN 1896090A
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- methyl
- halogen
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Steroid Compounds (AREA)
Abstract
Description
反应温度 | 反应时间(h) | Δ9(11)(%) | Δ11(12)(%) |
0℃ | 1 | 85.1 | 8.7 |
-10℃ | 1 | 88.4 | 5.9 |
-30℃ | 1.5 | 91.6 | 4.1 |
-50℃ | 2 | 95.5 | 2.6 |
-70℃ | 3 | 97.8 | 1.3 |
-85℃ | 3.5 | 98.5 | 1.2 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100144795A CN100551929C (zh) | 2005-07-14 | 2005-07-14 | Δ9(11)甾体类化合物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100144795A CN100551929C (zh) | 2005-07-14 | 2005-07-14 | Δ9(11)甾体类化合物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1896090A true CN1896090A (zh) | 2007-01-17 |
CN100551929C CN100551929C (zh) | 2009-10-21 |
Family
ID=37608751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100144795A Active CN100551929C (zh) | 2005-07-14 | 2005-07-14 | Δ9(11)甾体类化合物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100551929C (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9198921B2 (en) | 2010-04-05 | 2015-12-01 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-κB for treatment of disease |
CN107286215A (zh) * | 2016-03-31 | 2017-10-24 | 天津金耀集团有限公司 | 一种多个烯烃基团的甾体化合物制备方法 |
CN107540719A (zh) * | 2016-06-26 | 2018-01-05 | 浙江仙琚制药股份有限公司 | 一种17α‑乙酰氧基‑(8,13)‑烯‑11α‑羟基黄体酮的制备方法 |
CN110698528A (zh) * | 2019-11-19 | 2020-01-17 | 湖南新合新生物医药有限公司 | 甲基泼尼松龙中间体脱溴物及其制备方法 |
US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
US10857161B2 (en) | 2008-05-28 | 2020-12-08 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kB for treatment of disease |
CN114478674A (zh) * | 2021-12-24 | 2022-05-13 | 河南利华制药有限公司 | 一种二氟泼尼酯中间体的制备方法 |
US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105348351B (zh) * | 2015-11-16 | 2017-09-29 | 浙江仙琚制药股份有限公司 | 制备甲基四烯物的方法 |
-
2005
- 2005-07-14 CN CNB2005100144795A patent/CN100551929C/zh active Active
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11833159B2 (en) | 2008-05-28 | 2023-12-05 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kB for treatment of disease |
US10857161B2 (en) | 2008-05-28 | 2020-12-08 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kB for treatment of disease |
US9198921B2 (en) | 2010-04-05 | 2015-12-01 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-κB for treatment of disease |
US10000525B2 (en) | 2010-04-05 | 2018-06-19 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-κB for treatment of disease |
US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
US11690853B2 (en) | 2015-06-29 | 2023-07-04 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-κβ for treatment of disease |
CN107286215A (zh) * | 2016-03-31 | 2017-10-24 | 天津金耀集团有限公司 | 一种多个烯烃基团的甾体化合物制备方法 |
CN107540719B (zh) * | 2016-06-26 | 2020-02-21 | 浙江仙琚制药股份有限公司 | 一种17α-乙酰氧基-(8,13)-烯-11α-羟基黄体酮的制备方法 |
CN107540719A (zh) * | 2016-06-26 | 2018-01-05 | 浙江仙琚制药股份有限公司 | 一种17α‑乙酰氧基‑(8,13)‑烯‑11α‑羟基黄体酮的制备方法 |
US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
US11471471B2 (en) | 2019-03-07 | 2022-10-18 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
CN110698528A (zh) * | 2019-11-19 | 2020-01-17 | 湖南新合新生物医药有限公司 | 甲基泼尼松龙中间体脱溴物及其制备方法 |
CN110698528B (zh) * | 2019-11-19 | 2022-08-26 | 湖南新合新生物医药有限公司 | 甲基泼尼松龙中间体脱溴物及其制备方法 |
CN114478674A (zh) * | 2021-12-24 | 2022-05-13 | 河南利华制药有限公司 | 一种二氟泼尼酯中间体的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100551929C (zh) | 2009-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1896090A (zh) | Δ9(11)甾体类化合物的制备方法 | |
KR100226568B1 (ko) | 9,11 - 스테로이드의 레지오선택적 제조방법 | |
CN102143967B (zh) | 阿德福韦酯的纯化方法 | |
CN102040648A (zh) | Δ9(11)甾体类化合物的制备方法 | |
CN110407802B (zh) | 一种低聚合环状聚合物的制备方法及分离方法 | |
CN1514029A (zh) | 一种从磷灰石中提取稀土的方法 | |
CN1234675C (zh) | 2-烷基-2-金刚烷基酯的制备方法 | |
CN101440112B (zh) | 甾体化合物及其用途 | |
ES2565194T3 (es) | Procedimiento para la preparación de 17-desoxi-corticosteroides | |
CN112125943A (zh) | 一种高纯度16α-羟基泼尼松龙的制备方法 | |
CN111247160B (zh) | 一种胆酸类化合物的制备方法 | |
CN110698527A (zh) | 一种高纯度氢化可的松-17-戊酸酯的制备方法 | |
CN1869008A (zh) | 羟基和氨基同时保护的手性非α-氨基酸衍生物的制备方法 | |
CN1596241A (zh) | 6α-氟皮质甾类的制备方法 | |
CN1056614C (zh) | N-乙酰基氨基硫代磷酸o,s-二甲酯的提纯方法 | |
JP2008280304A (ja) | フルオロカルボン酸の製造方法 | |
CN114380661B (zh) | 一种(±)-薰衣草醇的合成方法 | |
CN111072746B (zh) | 一种6-α-乙基-7-酮基胆石酸的制备方法 | |
CN111072565A (zh) | 一种3-烷基吡唑及其制备方法 | |
CN111533657B (zh) | 一种三羟甲基丙烷油酸酯的纯化方法、制备方法 | |
CN109305981A (zh) | 2-羟基萘-1-硼酸的合成方法 | |
CN113121532B (zh) | 一种染料中间体的制备方法 | |
CN114853933B (zh) | 一种桦木醇衍生物基聚苯乙炔及其制备方法 | |
CN118085006A (zh) | 用于规模化制备布地奈德的方法 | |
US4159998A (en) | Process for the preparation of 2-(7-hydroxyalkyl)-4R, 4S or 4RS -hydroxy-cyclopent-2-enone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: Cheng linzhuan Hedong District of Tianjin City Road 300161 No. 91 Patentee after: Tianjin Pharmaceutical Research Institute Co.,Ltd. Address before: Cheng linzhuan Hedong District of Tianjin City Road 300161 No. 91 Patentee before: TIANJIN PHARMACEUTICALS Group Corp. |
|
CP01 | Change in the name or title of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 300457 Tianjin Binhai New Area Tianjin Development Zone West District Xinye Jiujie north, Xinhuan West Road East Patentee after: Tianjin Pharmaceutical Research Institute Co.,Ltd. Address before: Cheng linzhuan Hedong District of Tianjin City Road 300161 No. 91 Patentee before: Tianjin Pharmaceutical Research Institute Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 300457 North Xinye 9th Street and East Xinhuan West Road, West District, Binhai New Area Development Zone, Tianjin Patentee after: Tianjin Pharmaceutical Research Institute Co.,Ltd. Address before: 300457 Tianjin Binhai New Area Tianjin Development Zone West District Xinye Jiujie north, Xinhuan West Road East Patentee before: Tianjin Pharmaceutical Research Institute Co.,Ltd. |
|
CP02 | Change in the address of a patent holder |